Furthermore, dysregulated expression of MALAT-1 and ANRIL has been associated with the pathogenesis of SLE and correlated with disease activity, thereby indicating these two lncRNAs as potential biomarkers for SLE [53]. Here, MALAT1 is linked to systemic lupus erythematosus.